NRXP
NASDAQ
$4.18
NRX Pharmaceuticals Inc (NRXP)
NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $42 (+904.78%)
Market Cap
$149M
FCF 5Y CAGR
+92.04%
Free Cash Flow Yield
-10.00%
Beta (5Y)
1.07
Price Chart
Valuation
Market Cap$149M
Forward P/E34.25
P/S83.25
P/B2.90
Profitability
Total Revenue (TTM)$2.29M
Gross Profit (TTM)$1.16M
EBITDA-$17M
Operating Margin-444.6%
EPS-$1.15
Financial Health
Free Cash Flow Yield-10.00%
Growth & Risk
FCF 5Y CAGR+92.04%
Beta (5Y)1.07
Sharpe Ratio0.74